Practical Advice for Clinicians on the Imminent Arrival of hs-Troponin Assays
CSWN talks with James L. Januzzi, Jr, MD, director of the Cardiac Intensive Care Unit at Massachusetts General Hospital, about hs-troponin assays. This interview was conducted at ACC.15 in San Diego.
Видео Practical Advice for Clinicians on the Imminent Arrival of hs-Troponin Assays канала CSWNews
Видео Practical Advice for Clinicians on the Imminent Arrival of hs-Troponin Assays канала CSWNews
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
The LEGACY of Sustained Weight Loss: Reduction of AF Burden
Diabetes, Heart Failure, and Ischemic Heart Disease
Development and Validation of a Prediction Rule for Benefit and Harm of Long-Term DAPT After PCI
Anatomy vs. Physiology in CAD
Statistics show Investigators Often Fail Statistics
Two-year Results of the CoreValve US Pivotal Trial
Wearable Cardioverter Defibrillator: Mind the Gap Post-MI
We Are Not Alone: Intestinal Microbial Communities and the Congested Gut in Heart Failure
Ticagrelor as Long-Term Secondary Prevention in Patients with PAD and Prior MI
FDA Approves The First Subcutaneous ICD
PCSK9s: Now What?
JNC 8 Coming Soon. Really.
Multiple Arterial Coronary Bypass Grafting: Likely Better, But Not Yet a Mandate
Flash Lecture: Abdominal Fat and Risk
Hospital Length of Stay after Primary PCI among Elderly Patients: NCDR Report
Talking EXPLORER Trial Program with Anne Vosatka, MD, PhD
Sonothrombolysis: Ultrasound Impulses and Enhanced Myocardial Perfusion in PCI
PCSK9s: What's the Latest?
LEADERS FREE: The First Randomized Clinical Trial Dedicated to PCI in High-Bleeding Risk Patients
The Importance of Worsening HF in Ambulatory Patients
Exclusive Interview: The Third Universal Definition of MI